Edmonton, Alberta, Canada
October 31, 2013
Innovotech Inc. (TSX VENTURE:IOT) ("Innovotech") is pleased to announce the appointment of Robert Huizinga to its board of directors. Mr. Huizinga is currently Vice President, Clinical Affairs of Aurinia Pharmaceuticals Inc., formerly Isotechnika Pharma Inc. Prior to this, Mr. Huizinga was at the University of Alberta Hospitals in the Division of Nephrology & Immunology as a Nephrology Nurse Clinician and Research Epidemiologist. He holds a Master's Degree in Medical Sciences - Epidemiology, is a Registered Nurse and has published many articles with respect to his areas of expertise.
Dr. James Timourian, Chairman of the Board of Directors of Innovotech, states, "Mr. Huizinga has over twenty years of experience in clinical research. I look forward to the insights he will bring to the board of directors and believe his appointment will be a great asset to Innovotech."
As part of Mr. Huizinga's compensation for joining the board of directors, he will receive 30,000 stock options to purchase common shares of Innovotech at an exercise price of $0.085 per common share effective October 31, 2013 pursuant to Innovotech's stock option plan. The stock options expire October 30, 2023.
Mr. Huizinga replaces Dr. Lorne Babiuk who has tendered his resignation from the Board of Directors due to his many commitments as Vice President Research of the University of Alberta. Dr. Timourian added, "we sincerely thank Dr. Babiuk for his very valuable contributions of and consistent support for Innovotech, as well as for his offer to be available for consultation whenever needed."
Innovotech Inc. is a pioneer in the field of biofilm product development, focused on providing innovative and practical solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are organized communities of microorganisms that exist in virtually every natural environment and are responsible for a host of diseases in human health, animal health and agriculture. There are few products or regulatory standards, aside from those of Innovotech, designed specifically for biofilm-forming organisms.
Topics
Species
